Interactions between tumor cells and microenvironment in breast cancer: a new opportunity for targeted therapy

Shreya Mitra1, Katherine Stemke-Hale, Gordon B Mills

  • 1Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Cancer Science
|December 14, 2011
PubMed

Insights

Breast cancer relapse is influenced by the tumor microenvironment, not just tumor cells. Understanding these interactions offers new therapeutic targets for refractory breast cancer.

Area of Science:

  • Oncology
  • Cancer Biology
  • Tumor Microenvironment Research

Background:

  • Breast cancer is a leading cause of death in women, with many cases becoming refractory or recurrent.
  • Traditional research focuses on intrinsic tumor cell characteristics, neglecting the tumor microenvironment's role.
  • Emerging evidence highlights the tumor microenvironment's significant impact on breast cancer relapse and treatment outcomes.

Purpose of the Study:

  • To review the complex interactions between breast tumors and their microenvironment.
  • To identify potential therapeutic targets within these interactions, focusing on mutational profiles and metabolism.
  • To discuss current technologies for studying tumor-microenvironment interactions in breast cancer.

Main Methods:

  • Literature review of recent studies on breast cancer and tumor microenvironment.
  • Analysis of research on mutational profiles and metabolic alterations in breast cancer.
  • Overview of technological advancements for studying tumor-microenvironment dynamics.

Main Results:

  • The tumor microenvironment significantly influences breast cancer progression, relapse, and therapeutic response.
  • Specific mutational profiles and metabolic pathways within the tumor microenvironment present viable therapeutic targets.
  • Various technologies are available to investigate these intricate tumor-microenvironment interactions.

Conclusions:

  • Targeting the tumor microenvironment, alongside tumor cells, is crucial for overcoming breast cancer refractoriness and recurrence.
  • Further research into tumor-microenvironment interactions and associated metabolic and mutational changes is warranted.
  • Advancements in technology will facilitate a deeper understanding and more effective therapeutic strategies for breast cancer.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...